Team develops nanobody technology against liver inflammation

Mathieu Vinken, a professor in the In Vitro Toxicology and Dermato-cosmetology (IVTD) lab at the Vrije Universiteit Brussel, and doctoral student Raf Van Campenhout have developed a technique based on nanobody technology ...

When growth becomes a weakness for cancer cells

ETH researchers are shedding light on what can happen when cells exceed their normal size and become senescent. The new findings could help to optimize cancer therapies.

page 1 from 6